Lyndra Therapeutics
Watertown
About Lyndra Therapeutics
Lyndra Therapeutics is a company that develops medicines for long-term drug release in an oral dose form. The company is developing oral ultra-long-acting and sustained-release therapies for central nervous system (CNS) disorders for broad applicability across multiple therapeutic areas, including approved drugs, allowing the medical community to ensure improved medication adherence and health outcomes while also helping to lower healthcare costs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: $10K – $50K
- Total funding: $284.6M
- Funding stage: Late Stage Venture
- Last round: Series E (Dec 2023)
- Website: lyndra.com
- Phone: +1-857-304-4512
Industries & Categories
Biotechnology, Clinical Trials, Health Care, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/lyndra-therapeutics-105259 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.